To include your compound in the COVID-19 Resource Center, submit it here.

Celera sparks genomics sector

Investors responded favorably to the publication on Monday of the first drafts of the human genome by Celera (CRA) and the International Human Genome Consortium. The total market cap of the 10 genomic stocks tracked by BioCentury rose $724 million (6.2 percent)

Read the full 420 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers